Michael A. Brehm, PhD
-
Co-Director, UMass Chan Diabetes Center of Excellence
-
Professor of Medicine, The Harvey A. Shultz Chair in Diabetes
-
Academic Chief, Division of Diabetes, Endocrinology and Metabolism
-
Director, UMass Chan Humanized Mouse Core
-
Investigator, Breakthrough T1D Barbara Cammett Center of Excellence in New England
Dr. Brehm specializes in novel preclinical models that simulate human immune responses to investigate approaches for downregulating and activating the human immune system in the treatment of type 1 diabetes (T1D) and cancer. His laboratory examines human beta cells from individuals with T1D in vivo as they interact with intact immune systems from those same donors. The ultimate goal is to understand the etiology and pathogenesis of autoimmune T1D to develop new therapies or drugs for personalized medicine.
Lab News
-
Read more -
Researcher Spotlight: Mina Seedhom - Senior Research Scientist
Read more -
Michael Brehm Named UMass Chan DCOE Co-Director
Read more -
Lab Spotlight: Carey Zammitti - Research Associate
Read more -
Exploring CAR T Therapy Against Autoreactive T Cells
Read more